CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Net revenues	$ 12,371,673	$ 10,204,125
Costs and expenses:
Cost of services	10,133,005	7,567,868
General and administrative	3,836,475	4,237,203
Depreciation and amortization	164,658	63,751
Total costs and expenses	14,134,138	11,868,822
Loss from operations	(1,762,465)	(1,664,697)
Other income (expense)
Interest expense	(2,659)	(360,402)
Gain (loss) on change in fair value of warrant and conversion feature liabilities, net	822,222	(213,718)
Other income	1,971	101,004
Total other income (expense), net	821,534	(473,116)
Loss before (benefit) provision for income taxes	(940,931)	(2,137,813)
(Benefit) provision for income taxes	(41,553)	92,691
Net loss	(899,378)	(2,230,504)
Net income attributable to non-controlling interests	(415,879)	(251,862)
Net loss attributable to Apollo Medical Holdings, Inc.	$ (1,315,257)	$ (2,482,366)
Net loss per share:
Basic and diluted	$ (0.22)	$ (0.51)
Weighted average shares of common stock outstanding:
Basic and diluted	5,914,826	4,863,389